BioVie’s Bezisterim Shows Potential to Slow or Reverse Aging
BioVie Inc. presented data from its Phase 3 NM101 study on bezisterim, a drug candidate for Alzheimer’s diseaseAlzheimer’s disease,...
Fifty1 Labs Redefines Long COVID Treatment with AI
Fifty1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), has successfully completed its REVIVE Adaptive Platform...
Zervimesine in Alzheimer’s: Cognition Therapeutics and FDA Discuss Phase 2
Cognition Therapeutics met with the FDA to discuss Phase 2 trial results for their Alzheimer’s drug, zervimesine (CT1812), and...
PDS0101 Met Criteria for Expansion to Phase 2 Trial Following Positive Results
PDS Biotechnology Corporation announced positive results from Stage 1 of a National Cancer Institute (NCI)-led clinical trial for PDS01ADC,...
Artelo Biosciences: Positive Preclinical Efficacy of ART12.11 in Stress-Induced Depression
Artelo Biosciences announced preclinical data for its CBD-TMP cocrystal drug, ART12.11, at the International Cannabinoid Research Society Symposium. The...
Briquilimab Shows Promising Results in Chronic Urticaria Studies
Jasper Therapeutics has reported updated data from its BEACON Phase 1b/2a study of briquilimab, a subcutaneous antibody therapy for...
Bezuclastinib Shows Positive Top-Line Results in Summit Trial
Cogent Biosciences announced positive top-line results from its SUMMIT clinical trial of bezuclastinib for non-advanced systemic mastocytosis (NonAdvSM). The...
Plinabulin Boosts Dendritic Cell Growth, Fights Tumors After Checkpoint Inhibitor Failure
A recent study published in •Med• revealed that Plinabulin, in combination with radiation and PD-1 inhibitors, shows promise in...
Ashvattha Therapeutics Positive Interim Phase 2 Results for DME and Wet-AMD
Ashvattha Therapeutics announced interim Phase 2 trial results for its subcutaneous migaldendranib (MGB), a potential treatment for diabetic macular...
Chemomab Announces Positive Nebokitug Phase 2 Clinical Data in PSC at BSG ‘25
Chemomab Therapeutics announced positive Phase 2 SPRING trial data for nebokitug (CM-101) in patients with primary sclerosing cholangitis (PSC)...